Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Answers

Answers

Bernard Pirotte, Professor - Marianne Fillet, Professor - Philippe Hubert, Professor - Pierre Francotte, Assistant Professor

ULiège, CIRM - Royal Academy of Medicine of Belgium
" The pandemic has highlighted a critical need of local production of essential drugs used in first-line emergency care of COVID-19 patients. The present consortium has developed a dedicated unit to address this need (both organic synthesis and quality control) following strict quality assurance rules observed by the pharmaceutical industry. The pandemic has highlighted a critical need of local production of essential drugs used in first-line emergency care of COVID-19 patients. The present consortium has developed a dedicated unit to address this need (both organic synthesis and quality control) following strict quality assurance rules observed by the pharmaceutical industry. "
Contact: Prof. Marianne FILLET, CIRM Director, University of Liège https://www.cirm.uliege.be This email address is being protected from spambots. You need JavaScript enabled to view it.

Caroline Daelemans, Professor

ULB
"Our objectives are: • To study maternal and neonate COVID-19 information in the Belgian-Obstetric Surveillance System database: clinical presentation and natural history of disease, pregnancy-related basic information, pregnancy outcomes, birth characteristics, infant morbidity and mortality. • To study the core socio-demographic information to potentially identify groups at higher risk of complications • Build a more informative dataset thanks to data mining of public databases This study will enable us to understand the impact of COVID-19 on pregnant women and their offspring in Belgium, and in the world via the contribution to the INOSS multicenter study. It might allow us to define an at-risk population among pregnant women and their offspring, and tailor epidemiologic and clinical interventions for these more vulnerable individuals."
Funding: Pending (FNRS)
Publication References: "1. The International Network of Obstetric Survey Systems study of uterine rupture: a...

Caroline Daelemans, Professor

ULB
" COVerT Our aim is to delineate more accurately the prevalence of the infection in the pregnant population and study vertical transmission in the cord blood of babies born to mothers with confirmed SARS-CoV-2 infection. Determination of prevalence of SARS-CoV-2 infection in mothers by combined universal screening: presence of antibodies (IgG and IgM or IgA) in their blood and/or a positive RT-PCR in the nasopharyngeal swab. We intend to detect evidence of vertical transmission by the identification of SARS-CoV-2 specific IgM or IgA in cord blood samples. If there is evidence of vertical transmission, the analysis of the consequences depending on infection timing during pregnancy will enable us to guide management more precisely. "
Funding: pending FNRS
Publication References: "1. Delforge ML, Costa E, Brancart F, Goldman D, Montesinos I, Zaytouni S, Marchant A, Donner C Presence of cytomegalovirus in urine and blood of pregnant women with primary infection might be associated...

Cécile OURY, FNRS Research Director

GIGA - ULiège - FNRS
" Covid-19 is associated with a high risk of thrombotic disease, both in the venous and arterial circulations. As President of the Belgian Society on Thrombosis and Hemostasis (BSTH), I am coordinating the creation of national algorithms for thromboprophylaxis and anticoagulation of Covid-19 patients by a group of experts. These algorithms will be included in the Sciensano Covid-19 guidelines. "
Publication References: In preparation
Contact: Cécile Oury, PhD President of the Belgian Society on Thrombosis and Haemostasis Research Director F.R.S.-FNRS Head of the Laboratory of Cardiology GIGA-Cardiovascular Sciences University of Liège (B34) 1 Avenue de l'Hôpital 4000 Liège (Sart-Tilman) Belgium Tel: +32 (0)4 366 24 87 This email address is being protected from spambots. You need JavaScript enabled to view it.

Delphine Canivet, PhD

Erasme Hospital
" Objectifs : L'épidémie du coronavirus a eu des conséquences délétères sur la santé mentale de la population générale1,2. Aucune étude ne s'est encore penchée sur l'impact psychologique du coronavirus sur les proches des patients ayant été infectés par le covid-19. Cette étude permet de comparer les proches de patients survivants ayant séjourné ou n'ayant pas séjourné en soins intensifs, des proches de patients décédés. Méthodologie : Les familles (N=200) dont le proche a séjourné en soins intensifs ou en unité COVID à l'hôpital Erasme seront contactées par téléphone et invitées à compléter des questionnaires en ligne au minimum 1 mois après la sortie d'hospitalisation de leur proche, ou après son décès, et ensuite 6 mois après la première évaluation. Les variables psychologiques qui seront évaluées sont : (1) la qualité de vie (The Mc Gill Quality of Life Questionnaire), les symptômes anxieux et dépressifs (Hospital Anxiety and Depression Scale, HADS), les...

Jean-Paul Coutelier, FNRS Research Director, Professor

UCLouvain - FNRS
" A project developed by the Université d'Etat de Haïti will be supported. Its aim will be to test the possibility that the Moringa local plant may help to dicrease severity to disease through decrease of viral replication or enhancement of patient resistance. "
Funding: ARES-CCD
Contact: Prof. J.-P. Coutelier de Duve Institute Universite Catholique de Louvain SSS/DDUV - ICP Av. Hippocrate 75, bte B1.74.05 1200 Woluwe-Saint-Lambert Belgique tel 32 2 764 7437 fax 32 2 764 7430 e-mail This email address is being protected from spambots. You need JavaScript enabled to view it.
Comment: The project is developed by the Université d'Etat de Haïti, and is supported through an Institutional Support programme of ARES-CCD by looking at possible collaborations to perform it.

Jurga Marcin, PhD

EXO Biologics
" EXO Biologics plans to extend its research and development program towards the COVID-19 crisis by using its unique and disruptive technology based on Extracellular Vesicles. These nanometer size particles are gaining momentum in the scientific community as potential alternatives to stem cell and biologic drugs therapies in the fields of immunology, neurology, oncology, cardiology, gastroenterology among others. EXO Biologics has 12 years of experience in cell-based regenerative medicine and 8 years of experience in Extracellular Vesicles. Our advancements in research will play an important role for our company mission to provide affordable and accessible therapies to patients with unmet medical needs. "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Michel FREDERICH, Professor - Allison LEDOUX, Doctor - Mutien GARIGLIANY, Professor

ULiège, CIRM, FARAH
" Several natural products (i.e. lycorine, glycyrrhizine, extracts of Pelargonium, Echinacea, Sambucus,...) have shown activity against coronaviruses. Several plants have been used in Chinese Medicine to treat patients with COVID-19. The objective of this project is to evaluate several natural products against SARS-COV2 in vitro and confirm their potential for further development. "
Funding: Own funding.
Contact: Prof Michel FREDERICH https://www.cirm.uliege.be This email address is being protected from spambots. You need JavaScript enabled to view it.

Souad Rahmouni, Doctor

GIGA-Institute, ULiège - FNRS - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" The main objective of our research program is the identification of human genetic factors impacting the COVID19 pandemic. Within the COVID-19 host genetics initiative (https://www.covid19hg.org/), we will establish a shared set of phenotypes to be combined with genomic data for standard GWAS and further meta-analysis. Field of expertise of our laboratory : genetics, genomics, bioinformatics, immune-response related diseases. In addition, the GIGA Institute is an interdisciplinary research institute from the ULiege devoted to academic excellence in the biomedical sciences to foster ground-breaking medical innovation. It comprises 583 members attached to six faculties (Medicine, Science, Veterinary Medicine, Engineering, Agbiotech, Psychology) that are organized in four disease-based (neuroscience, cancer, infection-inflammation-immunity, cardiovascular) and two method-based thematic units...

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19